Results 151 to 160 of about 45,614 (245)
Lactobacillus paragasseri LG-1 Alleviates Urticaria-Like Symptoms in Mice via Modulation of Gut Microbiota, Hypoxanthine and Uric Acid. [PDF]
Wang Q +8 more
europepmc +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Global burden of urticaria in children and adolescents, 1990 to 2021: Trends, disparities, and future projections. [PDF]
Liu S, Jing X, Feng F, Wang H, He T.
europepmc +1 more source
Algorithms in Allergy: Hereditary Angioedema
Allergy, EarlyView.
Konrad Bork +3 more
wiley +1 more source
Correlation between IL-17 levels and chronic urticaria: Systematic review and meta-analysis. [PDF]
Wang L, Yao Y, Zhou J, Jiao Q, Ji J.
europepmc +1 more source
Adherence to e‐Diary reporting was investigated in a blended care setting among pollen allergic patients with heterogeneous cultural backgrounds. A stable ‘higher’ and a more variable ‘lower’ adherence cluster were identified. Early identification of lower adherence is possible and might inform early interventions to improve patient adherence. ABSTRACT
S. Dramburg +55 more
wiley +1 more source
Treatment response in chronic urticaria: analysis of clinical and laboratory predictors. [PDF]
Fonseca JTD +6 more
europepmc +1 more source

